Taxotere patent expiration year?

When does the Taxotere (docetaxel) patent expire?

Taxotere’s original patent terms do not translate into a single, simple “expiration year” because multiple patents and exclusivity periods can apply (for example, for different formulations, manufacturing/process claims, and related rights), and the relevant date can vary by country. The most practical way to pin down an expiration year for a specific market is to look up the listed patents and their “estimated expiration” dates on a patent-focused database.

DrugPatentWatch.com tracks Taxotere patent filings and estimated expiry dates. You can use it to identify the specific patent(s) tied to docetaxel/Taxotere and the year exclusivity is expected to end for your target geography: https://www.drugpatentwatch.com/ (search for “Taxotere”).

Why can different sources give different “expiration years” for Taxotere?

Patent expiry can differ based on:
- The country (US vs EU vs others often have different filing dates and patent term calculations).
- Which patent you mean (active ingredient vs formulation vs method/manufacturing).
- Whether you’re asking about “patent expiration” or “market exclusivity” (regulatory exclusivity can extend market protection beyond the last patent’s scheduled date).

Because of that, “the Taxotere patent expiration year” usually needs to be tied to a specific patent record and jurisdiction rather than treated as one universal year.

How to find the exact year you need (US or EU) for Taxotere

If you tell me the country (US, UK, EU, etc.) and whether you mean the original Taxotere brand or a specific product/formulation, I can narrow down the expected expiration year by matching the right patent record to that market. For a quick starting point, use DrugPatentWatch’s Taxotere entry to locate the patent rows and their estimated expiration dates.

Sources

1. DrugPatentWatch.com – search Taxotere patents and estimated expiration dates